Surgery News and Research

RSS

Hormone therapy reduces abnormal nerve growth in chronic back pain

Low back pain (LBP) is one of the most common health problems worldwide, affecting people of all ages and placing a heavy burden on healthcare systems. Many patients experience persistent discomfort that interferes with work, sleep, and daily activities.

4 Feb 2026

Small molecule targets glioblastoma oncogene in preclinical studies

UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, raising hopes that the molecule could become a much-needed new treatment for the deadliest brain cancer.

4 Feb 2026

When the doctor needs a checkup

He was a surgical oncologist at a hospital in a Southern city, a 78-year-old whose colleagues had begun noticing troubling behavior in the operating room.

4 Feb 2026

Ride Cincinnati grant funds research on immune activating wafer for glioblastoma treatment

A multidisciplinary team of University of Cincinnati Cancer Center researchers has received a $40,000 Ride Cincinnati grant to study a delayed release preparation, or wafer, of an immunostimulatory molecule to stimulate the central nervous system (CNS) immune system after surgery to remove glioblastoma, a form of primary brain cancer.

3 Feb 2026

New immunotherapy could replace daily pills after kidney transplantation

A new study offers hope that kidney transplant patients could one day have a monthly treatment instead of multiple pills every day.

3 Feb 2026

Why cardiologist evaluation matters after non-cardiac surgery

Interdisciplinary collaboration with cardiologists in non-cardiac surgery enhances patient outcomes, reducing cardiac event risks and improving survival rates.

3 Feb 2026

NIH grant disruptions slow down breast cancer research

Inside a cancer research laboratory on the campus of Harvard Medical School, two dozen small jars with pink plastic lids sat on a metal counter. Inside these humble-looking jars is the core of Joan Brugge's current multiyear research project.

3 Feb 2026

New prevention strategy can reduce deadly ovarian cancer risk by nearly 80%

A prevention strategy developed by Canadian researchers can reduce the risk of the most common and deadly form of ovarian cancer by nearly 80 per cent, according to a new study published today in JAMA Network Open by researchers at the University of British Columbia (UBC).

2 Feb 2026

Simpler hemiarch surgery effective for older aortic dissection patients

Ascending aortic hemiarch reconstruction offers the same long-term benefits to patients over age 65 with acute type A aortic dissection (ATAAD) as more complex extended arch reconstruction procedures, according to a study presented today at the 2026 Society of Thoracic Surgeons Annual Meeting.

1 Feb 2026

Age shapes long-term outcomes after multi-arterial CABG strategies

A late-breaking study drawing on more than 15 years of national outcomes data from the STS Adult Cardiac Surgery Database (ACSD) suggests that the two most commonly used multi-arterial coronary artery bypass grafting (CABG) strategies-bilateral internal thoracic artery (BITA) and single internal thoracic artery plus radial artery (SITA+RA)-offer comparable long-term survival overall, with important differences emerging by patient age.

31 Jan 2026

New model predicts redo surgery risk in adult congenital heart disease

Heart specialists at Mayo Clinic today presented new research at the 2026 Society of Thoracic Surgeons Annual Meeting that redo surgery for adults with congenital heart disease (CHD) remains high-risk, and a clinically applicable national risk assessment model is needed to help patients and care teams make decisions about procedures.

31 Jan 2026

Additional lymph node evaluation needed during surgery to accurately identify lung cancer spread

Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to accurately identify cancer spread.

31 Jan 2026

Eosinophils suppress tumor growth and recurrence in chordoma

Chordoma is a rare tumor characterized by poor prognosis, limited therapeutic options, and a high rate of recurrence. Despite advances in oncology, effective treatments for chordoma remain limited.

31 Jan 2026

Genetic ancestry influences tumor biology and survival in head and neck cancers

Genetic ancestry plays a key role in determining the behavior of head and neck tumors and may help explain why African-American patients survive for half as long as their counterparts of European ancestry, according to a new review study led by researchers from the University of Maryland School of Medicine's (UMSOM) Institute for Genome Sciences (IGS) and the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC).

31 Jan 2026

Study offers hope for preventing hydrocephalus in children

Hydrocephalus is a life-threatening condition that occurs in about 1 in 1,000 newborns and is often treated with invasive surgery. Now, a new study offers hope of preventing hydrocephalus before it even occurs.

30 Jan 2026

Cardiology consults post-surgery may reduce heart risks and mortality rates

An estimated 4.2 million people die within 30 days of surgery worldwide each year. A new study, published in the European Heart Journal today (Thursday), suggests that deaths and serious heart disease might be prevented if some patients see a specialist heart doctor as part of their post-surgery care.

30 Jan 2026

New wearable device may reduce hand tremors linked with neurological conditions

UBC Okanagan researchers have advanced their work on developing a non-invasive, accessible way to reduce uncontrolled hand tremors.

30 Jan 2026

Light-driven nanoparticles to target tumors

Researchers at NYU Abu Dhabi have developed a new light-based nanotechnology that could improve how certain cancers are detected and treated, offering a more precise and potentially less harmful alternative to chemotherapy, radiation, and surgery.

30 Jan 2026

Oral cancer pain and opioid tolerance share a common EGFR mechanism

Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and makes opioids less effective, according to new research published in Science Signaling.

29 Jan 2026

Treating desmoplastic melanoma with immunotherapy before surgery can shrink or eliminate tumors

New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and aggressive skin cancer, with immunotherapy before surgery can dramatically shrink or even eliminate tumors, sparing patients from more aggressive surgeries and preserving their quality of life.

29 Jan 2026